Safety and Efficacy of Intravenous IDOV-Immune in Patients With Advanced Solid Tumors
Safety and Efficacy of Intravenous IDOV-Immune in Patients With Advanced Solid Tumors
Enrolling by invitation · NCT07656090 · Registry updated 2026-06-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Intravenous IDOV-Immune in Patients With Advanced Solid Tumors | cancer, neoplasm | Enrolling by invitation | Early phase 1 | 2026-06-18 | NCT07656090 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 294 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cancer Hospital Chinese Academy of Medical Sciences | Beijing | China | 71 |